These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8387359)

  • 1. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu).
    Henklein P; Schubert U; Kunert O; Klabunde S; Wray V; Klöppel KD; Kiess M; Portsmann T; Schomburg D
    Pept Res; 1993; 6(2):79-87. PubMed ID: 8387359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
    Schubert U; Henklein P; Boldyreff B; Wingender E; Strebel K; Porstmann T
    J Mol Biol; 1994 Feb; 236(1):16-25. PubMed ID: 8107101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure and orientation of the transmembrane anchor domain of the HIV-1-encoded virus protein U by high-resolution and solid-state NMR spectroscopy.
    Wray V; Kinder R; Federau T; Henklein P; Bechinger B; Schubert U
    Biochemistry; 1999 Apr; 38(16):5272-82. PubMed ID: 10213635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy.
    Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP
    Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural consequences of phosphorylation of two serine residues in the cytoplasmic domain of HIV-1 VpU.
    Wittlich M; Koenig BW; Willbold D
    J Pept Sci; 2008 Jul; 14(7):804-10. PubMed ID: 18186541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR studies of the phosphorylation motif of the HIV-1 protein Vpu bound to the F-box protein beta-TrCP.
    Coadou G; Gharbi-Benarous J; Megy S; Bertho G; Evrard-Todeschi N; Segeral E; Benarous R; Girault JP
    Biochemistry; 2003 Dec; 42(50):14741-51. PubMed ID: 14674748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
    Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
    Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein.
    Friborg J; Ladha A; Göttlinger H; Haseltine WA; Cohen EA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):10-22. PubMed ID: 8548340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
    Raja NU; Jabbar MA
    Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of the transmembrane domain of Vpu in simian-human immunodeficiency virus (SHIVKU1bMC33) with that of M2 of influenza A results in a virus that is sensitive to inhibitors of the M2 ion channel and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Gomez LM; Fegley B; Mulcahy ER; Hill MS; Culley N; Pinson DM; Nothnick W; Powers MF; Wong SW; Stephens EB
    Virology; 2006 Jan; 344(2):541-59. PubMed ID: 16199074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 encoded virus protein U (Vpu) solution structure of the 41-62 hydrophilic region containing the phosphorylated sites Ser52 and Ser56.
    Coadou G; Evrard-Todeschi N; Gharbi-Benarous J; Benarous R; Girault JP
    Int J Biol Macromol; 2002 Mar; 30(1):23-40. PubMed ID: 11893391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains.
    Gomez LM; Pacyniak E; Flick M; Hout DR; Gomez ML; Nerrienet E; Ayouba A; Santiago ML; Hahn BH; Stephens EB
    Virology; 2005 Apr; 335(1):46-60. PubMed ID: 15823605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu).
    Federau T; Schubert U; Flossdorf J; Henklein P; Schomburg D; Wray V
    Int J Pept Protein Res; 1996 Apr; 47(4):297-310. PubMed ID: 8738656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional characterization of human SGT and its interaction with Vpu of the human immunodeficiency virus type 1.
    Dutta S; Tan YJ
    Biochemistry; 2008 Sep; 47(38):10123-31. PubMed ID: 18759457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between the cytoplasmic domains of HIV-1 Vpu and CD4: role of Vpu residues involved in CD4 interaction and in vitro CD4 degradation.
    Margottin F; Benichou S; Durand H; Richard V; Liu LX; Gomas E; Benarous R
    Virology; 1996 Sep; 223(2):381-6. PubMed ID: 8806575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP.
    Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP
    Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 VPU protein affects Sindbis virus glycoprotein processing and enhances membrane permeabilization.
    González ME; Carrasco L
    Virology; 2001 Jan; 279(1):201-9. PubMed ID: 11145902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.
    Deora A; Spearman P; Ratner L
    Virology; 2000 Apr; 269(2):305-12. PubMed ID: 10753709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.